Yang Wang

6PUBLICATIONS
5CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 24, 2026
Small-molecule DYRK1A Inhibitors for β-Cell Regeneration in Diabetes: Structural Insights and Medicinal Chemistry Advances.

|Aug 13, 2026
Targeting Telomerase Cajal Body Protein 1 (TCAB1) as a Novel Strategy for Discovering Potent Telomerase Inhibitors That Enhance Antitumor Immunity.

|Sep 01, 2025
Benzofuranyl-pyrazole as a Novel Scaffold for In Vitro and In Vivo Potent Anticancer Therapeutics That Directly Disrupt the 'Undruggable' MYC Oncogene and Potentiate Immune Checkpoint Blockage.

Liuqing Yang, Haojie Zuo, Mengdie Sha

|Aug 14, 2024
Small Molecules Blocking the Assembly of TCAB1 and Telomerase Complexes: Lead Discovery and Biological Activity.

Haojie Zuo, Yiming Ru, Xiuxiu Gao

|Jul 11, 2024
Directly Suppressing MYC Function with Novel Alkynyl-Substituted Phenylpyrazole Derivatives that Induce Protein Degradation and Perturb MYC/MAX Interaction.

Can Zhao, Fang Zhao, Liuqing Yang

|Jan 03, 2024
Targeted liposomes for macrophages-mediated pulmonary fibrosis therapy.

Yujie Wang, Fang Zhao, Xiangyu Wang

Pageof 1

Frequent Collaborators

4 joint publications

Xiaodong Ma

2 joint publications

Wenhu Zhan

2 joint publications

Xinhua Liu

1 joint publications

Xing Chen